Effect of Nicorandil in Type 2 Diabetic Obese Patients

Launched by TANTA UNIVERSITY · May 16, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a medication called nicorandil can help manage blood sugar levels and body weight in people with type 2 diabetes who are also obese. The study specifically focuses on participants who are currently using another type of diabetes medication called sulfonylureas. Researchers want to see if adding nicorandil to their treatment plan can improve their overall health.

To be eligible for this trial, participants need to be between 18 and 60 years old, have had diabetes for 1 to 10 years, and have a body mass index (BMI) over 30, which indicates obesity. Certain individuals, such as pregnant women or those with severe kidney or liver issues, cannot participate. If you join the study, you will receive more information about what to expect, including any tests or assessments that will be done. This trial is currently recruiting participants, so it’s a great opportunity for those who qualify to potentially benefit from a new treatment option.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diabetes duration ranged from 1 to 10 years.
• • Body mass index (BMI) \>30 Kg/m2.
• • The selected patients are treated with sulfonylureas alone.
• • The age of selected patient ranged from 18 and 60 years.
• Exclusion Criteria:
• • Pregnant and lactating females.
• • Patients with hypersensitivity to nicorandil.
• • Uncontrolled hypertension and its antihypertensive medications
• • Severe renal or hepatic disease.